About Innocule
Innocule is a company based in Bhubaneswar (India) founded in 2014 by Gyan Ranjan Das. Innocule has raised $957.94 thousand across 2 funding rounds from investors including Artha99, Pawan Agarwal and Surbhi Sarna. The company has 81 employees as of April 09, 2024. Innocule offers products and services including Grinex, Oreflo, FAM, Flumix, and Coalmix.
- Headquarter Bhubaneswar, India
- Employees 81 as on 09 Apr, 2024
- Founders Gyan Ranjan Das
- Stage Minicorn
-
Sectors
Chemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Innocule Materials And Additives Private Limited
- Date of Incorporation 11 Nov, 2014
- Jurisdiction Sarua, Orissa, India
-
Annual Revenue
$3.06 M (USD)44.88as on Mar 31, 2023
-
Net Profit
$179.73 K (USD)16.44as on Mar 31, 2023
-
EBITDA
$240.1 K (USD)-11.44as on Mar 31, 2023
-
Total Equity Funding
$957.94 K (USD)
in 2 rounds
-
Latest Funding Round
$957.94 K (USD), Seed
May 15, 2024
-
Investors
Artha99
& 2 more
-
Employee Count
81
as on Apr 09, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Innocule
Innocule offers a comprehensive portfolio of products and services, including Grinex, Oreflo, FAM, Flumix, and Coalmix.
Improves ball mill output and reduces power requirements effectively.
Reduces raw material stickiness to minimize operational downtime.
Increases production by decreasing moisture in filtration cakes.
Reduces silica and alumina content in various mineral ores.
Improves coke strength and reduces fines during processing.
Manages dust to enhance safety and operational efficiency.
Funding Insights of Innocule
Innocule has successfully raised a total of $957.94K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $957.94 thousand completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Innocule
Innocule has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include Artha99, Pawan Agarwal and Surbhi Sarna.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital investments in manufacturing ventures in India.
|
Locked | Locked | Locked | |
|
PA
Pawan Agarwal |
-
|
Locked | Locked | Locked |
|
SS
Surbhi Sarna |
Founder of nVision Medical, healthcare innovator, active angel investor
|
Locked | Locked | Locked |
Investor details for Innocule
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Innocule
Investment portfolio details for Innocule
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Innocule
Detailed financials for Innocule
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Innocule Comparisons
Peer comparison for Innocule
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Innocule
Detailed competitors of Innocule
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Innocule
Complete news archive for Innocule
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Innocule
Innocule was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Innocule is headquartered in Bhubaneswar, India. It is registered at Bhubaneswar, Odisha, India.
Innocule is a funded company, having raised a total of $957.94K across 2 funding rounds to date.
As of Apr 09, 2024, the latest employee count at Innocule is 81.
Annual revenue of Innocule is $3.06M as on Mar 31, 2023.
Provider of chemical solutions for efficient mineral processing. It offers customized solutions addressing challenges in mineral operations, such as low-grade ores and processing difficulties. These solutions aim to maximize output and minimize costs by improving grinding efficiency, reducing downtime caused by material stickiness, enhancing filtration production, and reducing impurities in ores. The solutions are designed for integration into existing plants without significant modifications. Products include solutions for improving grinding, filtration, and reducing impurities in various minerals, as well as enhancing coal quality.
Innocule offers Grinex, Oreflo, FAM, Flumix, and 2 more products and services.
Innocule has 3 investors. Key investors include Artha99, Pawan Agarwal, and Surbhi Sarna.
The valuation of Innocule is $13.83M as of May 2024.